REDHILL BIOPHARMA LTD-SP ADR (RDHL)
US7574682024 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 5.57M | 13.30M | 28.90M | 14.30M | 6.50M | |||
| Marketable Securities | 0.00 | 6.70M | 9.10M | 15.50M | 41.40M | |||
| Receivables | 2.59M | 34.50M | 31.70M | 28.70M | 1.20M | |||
| Inventories | 4.39M | 11.00M | 14.80M | 6.50M | 1.90M | |||
| Other Current Assets | 3.59M | 20.40M | 4.70M | 5.50M | 2.20M | |||
| Total Current Assets | 16.14M | 85.90M | 89.20M | 70.50M | 53.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.18M | 7.20M | 4.20M | 5.70M | 3.80M | |||
| Intangibles | 5.58M | 65.60M | 71.60M | 87.90M | 16.90M | |||
| Other Non-Current Assets | 147.00K | 200.00K | 16.20M | 16.20M | 200.00K | |||
| Total Non-Current Assets | 6.91M | 73.00M | 92.00M | 109.70M | 20.90M | |||
| TOTAL ASSETS | 23.05M | 158.90M | 181.20M | 180.20M | 74.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 718.00K | 116.20M | 1.60M | 1.70M | 800.00K | |||
| Accrued Expenses | 4.59M | 17.90M | 20.90M | 24.10M | 5.60M | |||
| Accounts Payable | 3.28M | 15.40M | 28.20M | 29.10M | 4.20M | |||
| Other Current Liabilities | 10.65M | 47.90M | 30.70M | 18.30M | N/A | |||
| Total Current Liabilities | 19.24M | 197.50M | 81.50M | 73.20M | 10.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 455.00K | 6.40M | 86.20M | 85.20M | 3.00M | |||
| Other Non-Current Liabilities | 1.28M | 3.40M | 4.60M | 7.90M | 500.00K | |||
| Total Non-Current Liabilities | 1.74M | 9.80M | 90.80M | 93.20M | 3.50M | |||
| TOTAL LIABILITIES | 20.98M | 207.30M | 172.30M | 166.40M | 14.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -407.74M | -433.90M | -367.90M | -280.30M | -208.40M | |||
| Additional Paid In Capital | 388.36M | 382.60M | 375.20M | 293.10M | 267.40M | |||
| Common Shares | 21.44M | 2.80M | 1.50M | 1.10M | 1.00M | |||
| Shares Outstanding | 96.78M | 11.46M | 6.44M | 47.22M | 43.38M | |||
| Tangible Book Value per Share | -0.00 | -0.12 | -0.12 | -0.02 | 0.01 | |||
| Total Shareholders' Equity | 2.07M | -48.40M | 8.90M | 13.90M | 60.00M | |||
| TOTAL LIABILITIES AND EQUITY | 23.05M | 158.90M | 181.20M | 180.20M | 74.10M | |||
| Statistics | ||||||||
| Debt/Equity | 0.22 | -0.13 | 9.69 | 6.13 | 0.05 | |||
| Current Ratio | 0.84 | 0.43 | 1.09 | 0.96 | 5.02 | |||
| Return On Assets (ROA) | 103.77% | -45.10% | -53.94% | -42.27% | -57.09% | |||
| Return On Equity (ROE) | 1155.92% | N/A | -1098.20% | -547.99% | -70.50% | |||
| Return On Invested Capital (ROIC) | 262.27% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 262.27% | N/A | N/A | N/A | N/A | |||
All data in USD